ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 83 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 2.13 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $3,000 | -76.9% | 967 | -74.3% | 0.00% | – |
| Q1 2020 | $13,000 | -85.7% | 3,765 | -75.1% | 0.00% | – |
| Q4 2019 | $91,000 | -2.2% | 15,111 | +21.8% | 0.00% | – |
| Q3 2019 | $93,000 | -43.3% | 12,408 | +2.1% | 0.00% | – |
| Q2 2019 | $164,000 | +1950.0% | 12,156 | +402.1% | 0.00% | – |
| Q4 2018 | $8,000 | -60.0% | 2,421 | +0.9% | 0.00% | – |
| Q3 2018 | $20,000 | -97.3% | 2,400 | -96.8% | 0.00% | – |
| Q2 2018 | $730,000 | +4766.7% | 75,000 | +6017.5% | 0.00% | – |
| Q4 2017 | $15,000 | -97.9% | 1,226 | -98.6% | 0.00% | – |
| Q3 2017 | $710,000 | +23566.7% | 85,000 | +46095.7% | 0.00% | – |
| Q2 2017 | $3,000 | – | 184 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 507,191 | $5,107,000 | 0.50% |
| Cormorant Asset Management, LP | 356,600 | $3,591,000 | 0.43% |
| Perceptive Advisors | 558,446 | $5,623,000 | 0.42% |
| NEXTHERA CAPITAL LP | 15,000 | $151,000 | 0.21% |
| EMERALD ADVISERS, LLC | 237,070 | $2,387,000 | 0.11% |
| AUXIER ASSET MANAGEMENT | 17,857 | $180,000 | 0.04% |
| FEDERATED HERMES, INC. | 450,000 | $4,532,000 | 0.01% |
| Nationwide Fund Advisors | 49,473 | $498,000 | 0.00% |
| Catalyst Capital Advisors LLC | 348 | $4,000 | 0.00% |
| DEUTSCHE BANK AG\ | 859 | $8,000 | 0.00% |